Citigroup’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $478K | Buy |
101,801
+5,475
| +6% | +$27.8K | ﹤0.01% | 3571 |
|
|
2025
Q4 | $410K | Buy |
96,326
+88,570
| +1,142% | +$336K | ﹤0.01% | 3668 |
|
|
2025
Q3 | $24.7K | Buy |
+7,756
| New | +$17.5K | ﹤0.01% | 4751 |
|
|
2024
Q2 | – | Sell |
-123,653
| Closed | -$270K | – | 5617 |
|
|
2024
Q1 | $270K | Buy |
+123,653
| New | +$228K | ﹤0.01% | 3887 |
|
|
2022
Q4 | – | Sell |
-795
| Closed | -$1K | – | 5804 |
|
|
2022
Q3 | $1K | Sell |
795
-882
| -53% | -$1.36K | ﹤0.01% | 5617 |
|
|
2022
Q2 | $3K | Sell |
1,677
-2,648
| -61% | -$5.07K | ﹤0.01% | 5766 |
|
|
2022
Q1 | $11K | Sell |
4,325
-126,444
| -97% | -$486K | ﹤0.01% | 5472 |
|
|
2021
Q4 | $566K | Buy |
130,769
+21,300
| +19% | +$125K | ﹤0.01% | 3697 |
|
|
2021
Q3 | $557K | Sell |
109,469
-191,688
| -64% | -$1.03M | ﹤0.01% | 3529 |
|
|
2021
Q2 | $1.91M | Buy |
301,157
+97,002
| +48% | +$755K | ﹤0.01% | 2700 |
|
|
2021
Q1 | $1.58M | Buy |
204,155
+192,708
| +1,683% | +$1.53M | ﹤0.01% | 2650 |
|
|
2020
Q4 | $75K | Buy |
11,447
+6,667
| +139% | +$47.6K | ﹤0.01% | 5760 |
|
|
2020
Q3 | $32K | Sell |
4,780
-32,778
| -87% | -$243K | ﹤0.01% | 5886 |
|
|
2020
Q2 | $313K | Buy |
37,558
+20,595
| +121% | +$191K | ﹤0.01% | 4664 |
|
|
2020
Q1 | $130K | Buy |
16,963
+3,350
| +25% | +$23.4K | ﹤0.01% | 5124 |
|
|
2019
Q4 | $113K | Sell |
13,613
-23,428
| -63% | -$158K | ﹤0.01% | 5665 |
|
|
2019
Q3 | $273K | Sell |
37,041
-54,947
| -60% | -$542K | ﹤0.01% | 4881 |
|
|
2019
Q2 | $1.03M | Buy |
91,988
+63,384
| +222% | +$665K | ﹤0.01% | 3587 |
|
|
2019
Q1 | $307K | Sell |
28,604
-101,904
| -78% | -$1.51M | ﹤0.01% | 4681 |
|
|
2018
Q4 | $1.97M | Buy |
130,508
+97,215
| +292% | +$1.44M | ﹤0.01% | 2680 |
|
|
2018
Q3 | $616K | Sell |
33,293
-9,935
| -23% | -$226K | ﹤0.01% | 4028 |
|
|
2018
Q2 | $988K | Buy |
43,228
+11,505
| +36% | +$294K | ﹤0.01% | 3373 |
|
|
2018
Q1 | $902K | Sell |
31,723
-6,104
| -16% | -$174K | ﹤0.01% | 3340 |
|
|
2017
Q4 | $799K | Buy |
37,827
+22,984
| +155% | +$477K | ﹤0.01% | 3582 |
|
|
2017
Q3 | $270K | Buy |
14,843
+14,768
| +19,691% | +$230K | ﹤0.01% | 4719 |
|
|
2017
Q2 | $1K | Sell |
75
-382
| -84% | -$5.76K | ﹤0.01% | 7129 |
|
|
2017
Q1 | $8K | Sell |
457
-20,201
| -98% | -$266K | ﹤0.01% | 6630 |
|
|
2016
Q4 | $227K | Buy |
20,658
+18,875
| +1,059% | +$229K | ﹤0.01% | 5171 |
|
|
2016
Q3 | $28K | Sell |
1,783
-383
| -18% | -$4.63K | ﹤0.01% | 6029 |
|
|
2016
Q2 | $22K | Sell |
2,166
-4,115
| -66% | -$46.9K | ﹤0.01% | 6095 |
|
|
2016
Q1 | $81K | Buy |
6,281
+3,969
| +172% | +$55.1K | ﹤0.01% | 5813 |
|
|
2015
Q4 | $48K | Buy |
+2,312
| New | +$36.6K | ﹤0.01% | 5964 |
|
Other funds holding CTMX
KCM
PA
VA
VCM
